| Gene symbol | FLT1 | Synonyms | FLT, FLT-1, VEGFR-1, VEGFR1 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q12.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | fms related receptor tyrosine kinase 1 | ||||
| GTO ID | GTC1184 |
| Trial ID | NCT00021021 |
| Disease | Kidney Cancer |
| Altered gene | VEGFR1 |
| Therapeutic/Target gene | Target gene |
| Therapy | Ribozyme |
| Treatment | RPI.4610 |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | A Phase II, Open-Label, Multicenter Trial of Angiozyme in Subjects With Metastatic Renal Cell Cancer |
| Year | 2001 |
| Country | United States |
| Company sponsor | Ribozyome |
| Other ID(s) | CDR0000068739|UCLA-001201501|RPI-0004|NCI-G01-1975 |
| Cohort 1 | |||||||
|
|||||||